Prevention and treatment of osteoporosis in the cystic fibrosis population

Journal of Pediatric Health Care

Volumn 15, Issue 6, 2001, Pages 308-315

  Robinson, Renne F ^a   Nahata, Milap C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CYSTIC FIBROSIS; HUMAN; NURSE PRACTITIONER; NURSING EDUCATION; OSTEOPOROSIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

CHILD; CYSTIC FIBROSIS; EDUCATION, NURSING, CONTINUING; HUMANS; NURSE PRACTITIONERS; OSTEOPOROSIS; RISK FACTORS;

EID: 0040152025     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1067/mph.2001.119354     Document Type: Article

References (51)

1. Adinoff, A. D., & Hollister, J. R. (1983). Steroid-induced fractures and bone loss in patients with asthma. New England Journal of Medicine, 309, 265-268.
2. Aris, R. M., Lester, G. E., Renner, J. B., Winders, A., Denene Blackwood, A., Lark, R. K., et al. (2000). Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. American Journal of Respiratory and Critical Care Medicine, 162, 941-946.
3. Aris, R. M., Neuringer, I. P., Weiner, M. A., Egan, T. M., & Ontjes, D. (1996). Severe osteoporosis before and after lung transplantation. Chest, 109, 1176-1183.
4. Aris, R. M., Renner, J. B., Winders, A. D., Buell, H. E., Riggs, D. B., Lester, G. E., et al. (1998). Increased rate of fractures and severe kyphosis: Sequelae of living into adulthood with cystic fibrosis. Annals of Internal Medicine, 128, 186-193.
5. Bachrach, L. K., Loutit, C. W., & Moss, R. B. (1994). Osteopenia in adults with cystic fibrosis. American Journal of Medicine, 96, 27-34.
6. Baroncelli, G. I., De Luca, F., Magazzu, G., Arrigo, T., Sferlazzas, C., Catena, C., et al. (1997). Bone demineralization in cystic fibrosis: Evidence of imbalance between bone formation and degradation. Pediatric Research, 41, 397-403.
7. Beauchesne, M. F., & Miller, P. F. (1999). Etidronate and alendronate in the treatment of postmenopausal osteoporosis. The Annals of Pharmacotheracotherapy, 33, 587-599.
8. Bhudhikanok, G. S., Lim, J., Marcus, R., Harkins, A., Moss, R. B., & Bachrach, L. K. (1996). Correlates of osteopenia in patients with cystic fibrosis. Pediatrics, 97, 103-111.
9. Bilton, D., Dodd, M. E., Abbot, J. V., & Webb, A. K. (1992). The benefits of exercise combined with physiotherapy in the treatment of adults with cystic fibrosis. Respiratory Medicine, 86, 507-511.
10. Calcium supplements. (2000). Medical Letter on Drugs and Therapeutics, 42, 29-31.
11. Cann, C. E., Martin, M. C., Genant, H. K., & Jaffe, R. B. (1984). Decreased spinal mineral content in amenorrheic women. Journal of the American Medical Association, 251, 626-629.
12. Chan, G. M. (1992). Performance of dual-energy x-ray absorptiometry in evaluating bone, lean body mass, and fat in pediatric subjects. Journal of Bone and Mineral Research, 7, 369-374.
13. Chapuy, M. C., Arlot, M. E., Delmar, P. D., & Meunier, P. J. (1994). Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. British Medical Journal, 308, 1081-1082.
14. Chesney, R. W., Rosen, J. F., Hamstra, A. J., Smith, C., Mahaffey, K., & DeLuca, H. F. (1981). Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. Journal of Clinical Endocrinology and Metabolism, 53, 139-142.
15. Christiansen, C. (1995). Osteoporosis: diagnosis and management today and tomorrow. Bone, 17(5 Suppl), 513S-516S.
16. de Groen, P. C., Lubbe, D. F., Hirsch, L. J., Daifotis, A., Stephenson, W., Freedholm, D., et al. (1996). Esophagitis associated with the use of alendronate. New England Journal of Medicine, 335, 1016-1021.
17. De Schepper, J., Smitz, J., Dab, I., Piepsz, A., Jonckheer, M., & Bergmann, P. (1993). Low serum bone gamma-carboxyglutamic acid protein concentrations in patients with cystic fibrosis: Correlation with hormonal parameters and bone mineral density. Hormone Research, 39, 197-201.
18. Donovan, D. S., Jr., Papadopoulos, A., Staron, R. B., Addesso, V., Schulman, L., McGregor, C., et al. (1998). Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. American Journal of Respiratory and Critical Care Medicine, 157, 1892-1899.
19. Eriksen, E. F., Mosekilde, L., & Melsen, F. (1985). Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics. Bone, 6, 381-389.
20. Ettinger, B., Black, D. M., Mitlak, B. H., Knickerbocker, R. K., Nickelsen, T., Genant, H. K., et al. (1999). Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators [published erratum appears in Journal of the American Medical Association 1999 Dec 8;282:2124]. Journal of the American Medical Association, 282, 637-645.
21. Finkelstein, S. M., Wielinski, C. L., Elliott, G. R., Warwick, W. J., Barbosa, J., Wu, S. C., et al. (1988). Diabetes mellitus associated with cystic fibrosis. Journal of Pediatrics, 112, 373-377.
22. Gallacher, S. J., Fenner, J. A., Anderson, K., Bryden, F. M., Banham, S. W., Logue, F. C., et al. (1992). Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: An open pilot study. Thorax, 47, 932-936.
23. Gardsell, P., Johnell, O., & Nilsson, B. E. (1989). Predicting fractures in women by using forearm bone densitometry. Calcified Tissue International, 44, 235-242.
24. Gibbens, D. T., Gilsanz, V., Boechat, M. I., Dufer, D., Carlson, M. E., & Wang, C. I. (1988). Osteoporosis in cystic fibrosis. Journal of Pediatrics, 113, 295-300.
25. Greenspan, S. L., Neet, R. M., Ridgway, E. C., & Klibanski, A. (1986). Osteoporosis in men with hyperprolactinemic hypogonadism. Annals of Internal Medicine, 104, 777-782.
26. Grey, A. B., Ames, R. W., Matthews, R. D., & Reid, I. R. (1993). Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax, 48, 589-593.
27. Haworth, C. S., Selby, P. L., Webb, A. K., Adams, J. E., & Freemont, T. J. (1999). Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis. Lancet, 353, 1886.
28. Henderson, R. C., & Lester, G. (1997). Vitamin D levels in children with cystic fibrosis. Southern Medical Journal, 90, 378-383.
29. Henderson, R. C., & Madsen, C. D. (1996). Bone density in children and adolescents with cystic fibrosis. Journal of Pediatrics, 128, 28-34.
30. Kanis, J. A. (1993). Treatment of symptomatic osteoporosis with fluoride. American Journal Medicine, 95, 53S-61S.
31. Levin, M. E., Boisseau, V. C., & Aviall, L. V. (1976). Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. New England Journal of Medicine, 294, 241-245.
32. Lips, P. (1994). Suboptimal vitamin D status: a risk factor for osteoporosis? Advances in Nutritional Research, 9, 151-166.
33. Maton, P. N., & Burton, M. E. (1999). Antacids revisited: A review of their clinical pharmacology and recommended therapeutic use. Drugs, 57, 855-870.
34. McNaughton, S. A., Stormont, D. A., Shepherd, R. W., Francis, P. W., & Dean, B. (1999). Growth failure in cystic fibrosis. Journal of Paediatric Child Health, 35, 86-92.
35. Mischler, E. H., Chesney, P. J., Chesney, R. W., & Mazess, R. B. (1979). Demineralization in cystic fibrosis detected by direct photon absorptiometry. American Journal of Diseases of Children, 133, 632-635.
36. Ott, S. M., & Aitken, M. L. (1998). Osteoporosis in patients with cystic fibrosis. Clinics in Chest Medicine, 19, 555-567.
37. Pamidronate. (1992). Medical Letter on Drugs and Therapeutics, 34, 1-2.
38. Raloxifene for postmenopausal osteoporosis. (1998). [Published erratum appears in Medical Letter on Drugs and Therapeutics 1998 May 8;40:54]. Medical Letter on Drugs and Therapeutics, 40, 29-30.
39. Ramsey, B. W., Farrell, P. M., & Pencharz, P. (1992). Nutritional assessment and management in cystic fibrosis: A consensus report. The Consensus Committee. American Journal of Clinical Nutrition, 55, 108-116.
40. Reginster, J. Y. (1992). Management of high turn-over osteoporosis with calcitonin. Bone, 13 (Suppl2), S37-40.
41. Reginster, J. Y. (1993). Calcitonin for prevention and treatment of osteoporosis. American Journal of Medicine, 95, 44S-47S.
42. Riggs, B. L., & Melton, L. J. III. (1992). The prevention and treatment of osteoporosis [published erratum appears in New England Journal of Medicine 1993 Jan 7;328:65]. New England Journal of Medicine, 327, 620-627.
43. Rosen, C. J., & Tenenhouse, A. (1998). Biochemical markers of bone turnover. A look at laboratory tests that reflect bone status. Postgraduate Medicine, 104, 101-102, 107-110, 113-114.
44. Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., et al. (1998). Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. New England Journal of Medicine, 339, 292-299.
45. Sanchez, I., & Guiraldes, E. (1995). Drug management of noninfective complications of cystic fibrosis. Drugs, 50, 626-635.
46. Southgate, D. A., Widdowson, E. M., Smits, B. J., Cooke, W. T., Walker, C. H., & Mathers, N. P. (1969). Absorption and excretion of calcium and fat by young infants. Lancet, 1, 487-489.
47. Stamatakis, M. K., Alderman, J. M., & Meyer-Stout, P. J. (1998). Influence of pH on in vitro disintegration of phosphate binders. American Journal of Kidney Diseases, 32, 808-812.
48. Thiebaud, D., Burckhardt, P., Kriegbaum, H., Huss, H., Mulder, H., Juttmann, J. R., et al. (1997). Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis. American Journal of Medicine, 103, 298-307.
49. Thomas, T. N. (1997). Lifestyle risk factors for osteoporosis. Medsurg Nursing, 6, 275-277, 287.
50. Walsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996). Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study. British Medical Journal, 313, 344-346.
51. Zaidi, M., Moonga, B. S., & Adebanjo, O. A. (1999). Novel mechanisms of calcium handling by the osteoclast: A review-hypothesis. Proceedings of the Association of American Physicians, 111, 319-327.